IP Library › Granted Patent US 11,098,321
Granted Patent B2
US 11,098,321 · App. 16/110,991 · Granted Aug 24, 2021

Transgenic maize event MON 87419 and methods of use thereof

Inventors: Wen C. Burns (Chesterfield, MO); Michael E. Goley (St. Louis, MO); Jintai Huang (Chesterfield, MO); Melinda C. McCann (St. Louis, MO); Aihua Shao (St. Louis, MO); Oscar C. Sparks (St. Louis, MO); Martin A. Stoecker (St. Louis, MO); Liping Wei (St. Louis, MO)
Assignee: Monsanto Technology LLC
C12N15/8274A01N37/40A01N57/20C12Q1/6895C12Q2600/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,098,321
App. No.
16/110,991
Granted
Aug 24, 2021
Kind
B2
Abstract

The invention provides recombinant DNA molecules that are unique to the maize MON 87419 event and transgenic maize plants, plant parts, seeds, cells, and agricultural products containing the MON 87419 event as well as methods of using and detecting the maize MON 87419 event. Transgenic maize plants containing the MON 87419 event exhibit tolerance to dicamba and glufosinate herbicides.

Claims (2)

1. A transgenic maize plant, seed, cell, plant part, or commodity product comprising a DNA molecule comprising SEQ ID NO: 1 and SEQ ID NO: 2 flanking a nucleic acid molecule encoding a dicamba mono-oxygenase protein and a phosphinothricin acetyltransferase protein.

2. The transgenic maize plant, seed, cell, plant part, or commodity product of claim 1 , wherein the DNA molecule comprises SEQ ID NO:10.

Continuity (3)
Division 14643650 · Mar 10, 2015
Provisional Application 61968342 · Mar 20, 2014
Related Publication 20190055575A1 · Feb 21, 2019
Cited By (1)
US 12,252,696